A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity

Abstract

Many public health responses and modeled scenarios for COVID-19 outbreaks caused by SARS-CoV-2 assume that infection results in an immune response that protects individuals from future infections or illness for some amount of time. The presence or absence of protective immunity due to infection or vaccination (when available) will affect future transmission and illness severity. Here, we review the scientific literature on antibody immunity to coronaviruses, including SARS-CoV-2 as well as the related SARS-CoV, MERS-CoV and endemic human coronaviruses (HCoVs). We reviewed 2,452 abstracts and identified 491 manuscripts relevant to 5 areas of focus: 1) antibody kinetics, 2) correlates of protection, 3) immunopathogenesis, 4) antigenic diversity and cross-reactivity, and 5) population seroprevalence. While further studies of SARS-CoV-2 are necessary to determine immune responses, evidence from other coronaviruses can provide clues and guide future research.

Cited by papers we hold 39

• SARS-CoV-2 Mutations and Their Impact on Diagnostics, Therapeutics and Vaccines · 2022
  No notice
• SARS-CoV-2 antibody progression and neutralizing potential in mild symptomatic COVID-19 patients – a comparative long term post-infection study · 2022
  Not checked
• Kinetics of humoral immune response over 17 months of COVID-19 pandemic in a large cohort of healthcare workers in Spain: the ProHEpiC-19 study · 2022
  Not checked
• Development of at-home sample collection logistics for large-scale seroprevalence studies. · 2021
  Not checked
• Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6–8 months after the infection · 2021
  No notice
• The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation · 2021
  Corrected
• Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection · 2021
  No notice
• Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates · 2021
  No notice
• Cross-reactive CD4 + T cells enhance SARS-CoV-2 immune responses upon infection and vaccination · 2021
  No notice
• Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals · 2021
  No notice
• Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19 · 2021
  No notice
• Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset · 2021
  Not checked
• Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19 · 2021
  No notice
• Peripheral and lung resident memory T cell responses against SARS-CoV-2 · 2021
  No notice
• SARS-CoV-2-specific T cells in infection and vaccination · 2021
  No notice
• T cell response to SARS-CoV-2 infection in humans: A systematic review · 2021
  No notice
• Immunological characteristics govern the transition of COVID-19 to endemicity · 2021
  No notice
• SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay · 2021
  No notice
• COVID-19 false dichotomies and a comprehensive review of the evidence regarding public health, COVID-19 symptomatology, SARS-CoV-2 transmission, mask wearing, and reinfection · 2021
  No notice
• Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States · 2021
  No notice

and 19 more

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.